Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, some people on Wegovy do notice a bad taste in their mouth, particularly in the early weeks of treatment. It is not the most talked-about side effect, but it is real and documented. The NHS lists taste changes among the reported effects of semaglutide, and clinical trial data confirm that altered or unpleasant taste occurs across the GLP-1 class. It tends to be mild and transitory, settling as the body adjusts to the medicine. As with all effects linked to Wegovy, a prescriber should be your first point of contact if it becomes persistent or troubling — these are prescription-only medicines, and suitability is assessed individually.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (the large phase-3 study of semaglutide 2.4mg published in the New England Journal of Medicine) reported gastrointestinal effects as the primary side-effect category, with nausea, vomiting and diarrhoea leading. Taste disturbance sits within a broader category of GI and neurological effects that the trial and subsequent post-marketing reports have documented. The NHS semaglutide medicines page lists "changes to your sense of taste" as one of the uncommon effects (experienced by fewer than 1 in 100 people) though reports in practice suggest the number who notice some shift in how things taste is higher, particularly at the start of a new dose level. The taste is variously described as metallic, bitter, artificially sweet or just "off". It is rarely the reason someone stops treatment, but it can affect appetite and mealtimes in ways that are worth understanding rather than simply tolerating. A question our prescribers hear most weeks during the early-escalation phase is whether the strange taste will go away. The honest answer from the evidence is: for most people, yes.
There is no single mechanism. Semaglutide slows gastric emptying, food sits in the stomach longer, and that can change how flavours register and linger. GLP-1 receptors exist not only in the gut but in the brain, including areas involved in taste perception and appetite, so direct central effects are plausible. During periods of nausea, saliva production can drop or change in composition, which in turn dulls or distorts flavour. Some people also find that heightened sensitivity to smell (another reported GLP-1 effect) makes the overall eating experience feel unfamiliar. For fuller context on how taste symptoms fit within the wider side-effect picture, the strange taste in mouth on Wegovy page covers the range of sensory changes people describe. Metallic taste specifically is explored on the bad taste in mouth on Wegovy page, and if the sensation is more sweet or chemical than metallic, the sweet taste in mouth on semaglutide guide addresses that variation directly. The short version: the taste change is a real physiological phenomenon, not imagined, and the mechanisms overlap with the same GI and neural pathways that produce nausea.
Taste changes are most common in the first few days after starting a new dose level. The escalation schedule for Wegovy moves through several dose steps, and each step can bring a brief recurrence. That pattern is consistent with the known pharmacokinetics: blood levels peak around 24–48 hours after injection and gradually decline over the week. Most people find the taste settles within one to two weeks of holding a stable dose. A minority continue to notice it throughout treatment, usually at a low level. If you find the effect is affecting your enjoyment of food substantially, it is worth logging when it occurs relative to your injection day, that information is useful to your prescriber. Our Wegovy and funny taste in mouth page has practical notes on this. Semaglutide is the active ingredient in both Wegovy and Ozempic; if you are curious about whether the effect differs by formulation, the semaglutide and bad taste page goes into that comparison. The oral Wegovy tablet, approved by the MHRA in June 2026, involves a different absorption route and some users report the mouth and taste experience differs from the injection, something prescribers are gathering more information on as clinical experience grows.
For most people the taste change is an inconvenience rather than a medical concern. Staying hydrated helps, dehydration worsens taste distortion and is already a risk when nausea reduces the desire to drink. Rinsing with plain water after the nausea or unpleasant taste peaks, choosing cooler foods (which carry less aroma than hot meals), and eating slowly tend to help. Acidic drinks and very sweet foods can amplify the effect for some, so a brief trial of avoiding them around injection day is reasonable. Zinc deficiency can also cause taste changes and is sometimes exacerbated when caloric intake drops sharply, worth mentioning to a prescriber if you are eating considerably less. Separately, if you are weighing up the cost of private treatment, the Wegovy cost in the UK page gives a clear breakdown of what to expect from private providers. If you want to read more about Wegovy as a medicine, the semaglutide overview covers the full picture. The situations where taste change needs prompt attention are: if it is accompanied by significant nausea, vomiting and persistent stomach pain (particularly pain radiating to the back, which can signal pancreatitis, seek urgent medical help in that case), or if you notice the taste worsening rather than improving after several weeks at a stable dose. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is the right place to report any side effects that concern you, and doing so genuinely helps regulators understand how the medicine performs in real-world use.
If you are thinking about starting Wegovy and have questions about what to expect, our prescribers can talk through your individual picture. Check your eligibility with a free consultation, every application is reviewed by a GPhC-registered prescriber, not automated software, on the same day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.